Biomerica, Inc. (BMRA) Balance Sheet

NASDAQ: BMRAAssets, liabilities, debt and equity over 10 years.

BMRA balance sheet, FY2026

May 31, 2026 · U.S. dollars

$6.8M assets = $4.1M liabilities + $2.6M equity

What it owns$6.8MCash & ST investments: $1.3M (19.4%)Cash & ST investments$1.3M · 19%Receivables: $785,000 (11.6%)Receivables$785,000 · 12%Inventory: $1.7M (25.3%)Inventory$1.7M · 25%Other current: $216,000 (3.2%)PP&E: $2.0M (28.9%)PP&E$2.0M · 29%Goodwill & intangibles: $209,000 (3.1%)LT investments: $500,000 (7.4%)LT investments $500,000Other non-current: $83,000 (1.2%)=How it is financed$6.8MCurrent liabilities: $2.5M (36.7%)Current liabilities$2.5M · 37%Other LT liabilities: $1.6M (24.4%)Other LT liabilities$1.6M · 24%Shareholders’ equity: $2.6M (38.9%)Shareholders’ equity$2.6M · 39%

Both columns are drawn to the same scale: what BMRA owns equals what it owes plus shareholders’ equity. Hover a block for its value.

BMRA financial health

Current ratio1.62
Comfortable · current assets cover current liabilities 1.62×
Debt / equity0.91
Moderate leverage · $0.91 of debt for each $1 of equity
Equity / assets38.9%
Balanced · of assets funded by shareholders
Cash / debt54.9%
Partial cover · cash & short-term investments vs total debt
Goodwill & intangibles3.1%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal FY2026.

BMRA balance sheet trends, FY2017–FY2026

Biomerica, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$5.0MFY2017$6.8MFY2026+3.4%/yr
Total liabilities$528,866FY2017$4.1MFY2026+25.7%/yr
Shareholders’ equity$4.5MFY2017$2.6MFY2026−5.8%/yr
Cash & short-term investments$1.2MFY2017$1.3MFY2026+0.7%/yr
Total debt$1.8MFY2020$2.4MFY2026+5.0%/yr
Net cash (debt)$6.9MFY2020−$1.1MFY2026−$7.9M
Working capital$3.7MFY2017$1.5MFY2026−$2.1M
Book value per share$0.54FY2017$0.90FY2026+5.9%/yr
Current ratio7.96FY20171.62FY2026−6.34
Debt / equity0.13FY20200.91FY2026+0.78
Shares outstanding8.3MFY20172.9MFY2026−11.0%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

BMRA assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

BMRA liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

BMRA debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

BMRA balance sheet

Biomerica, Inc. annual balance sheet
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Assets
Cash & short-term investments$1.3M$2.4M$4.2M$9.7M$5.9M$4.2M$8.6M$686,785$1.2M$1.2M
Cash & equivalents$1.3M$2.4M$4.2M$9.7M$5.9M$4.2M$8.6M$686,785$1.2M$1.2M
Short-term investments————————$0$0
Receivables$785,000$731,000$947,000$722,000$773,818$1.5M$1.8M$1.5M$799,940$1.1M
Inventory$1.7M$1.5M$2.4M$2.1M$2.4M$3.2M$2.9M$2.2M$2.2M$1.7M
Other current assets$216,000$255,000$238,000$300,000$320,730$370,545$1.5M$202,402$300,409$195,757
Total current assets$4.0M$4.9M$7.7M$12.8M$9.4M$9.2M$14.8M$4.5M$4.5M$4.2M
Property, plant & equipment (net)$2.0M$564,000$943,000$1.2M$1.5M$1.9M$2.0M$351,070$351,149$331,857
Goodwill & intangible assets$209,000$228,000$212,000$165,000$170,000$294,830$168,655$107,209$98,923$174,469
Long-term investments$500,000$165,000$165,000$165,000$165,324$165,324$165,324$165,324$165,324$165,324
Other non-current assets$83,000$113,000$203,000$79,000$95,951$264,151$168,193$126,832$123,157$135,989
Total assets$6.8M$5.9M$9.3M$14.5M$11.4M$11.8M$17.3M$5.2M$5.2M$5.0M
Liabilities
Accounts payable$377,000$295,000$288,000$344,000$736,000$431,000$833,412$999,593$655,599$336,430
Short-term debt$735,000$358,000$326,000$297,000$341,000$327,944$211,809———
Deferred revenue$83,000$55,000$85,000$60,000$51,000—————
Total current liabilities$2.5M$1.7M$2.2M$1.9M$2.0M$1.3M$1.5M$1.3M$896,808$528,866
Long-term debt$0$0$0$0$0$0$0$0$0$0
Lease obligations$1.9M$458,000$785,000$1.1M$1.4M$1.6M$1.8M———
Other long-term liabilities$1.6M$100,000$459,000$785,000$1.0M$1.3M$1.6M$999,593$0$8,000
Total liabilities$4.1M$1.8M$2.7M$2.7M$3.0M$2.6M$3.0M$1.3M$896,808$528,866
Shareholders' equity
Common stock & paid-in capital$255,000$203,000$1.3M$1.3M$1.0M$984,571$939,205$774,173$711,040$680,893
Retained earnings (deficit)−$56.9M−$53.2M−$48.2M−$42.2M−$35.1M−$30.5M−$21.9M−$19.6M−$17.2M−$15.7M
Treasury stock————————$0$0
Accumulated other comprehensive income−$108,000−$105,000−$102,000−$110,000−$73,936−$47,956−$39,841−$36,531−$26,136−$15,834
Minority interest————————$0$0
Total shareholders' equity$2.6M$4.1M$6.6M$11.7M$8.3M$9.2M$14.2M$4.0M$4.3M$4.5M
Key figures
Total debt$2.4M$458,000$785,000$1.1M$1.4M$1.6M$1.8M———
Net cash (debt)−$1.1M$1.9M$3.4M$8.6M$4.5M$2.6M$6.9M———
Working capital$1.5M$3.1M$5.5M$10.9M$7.4M$7.9M$13.3M$3.2M$3.6M$3.7M
Tangible book value$2.4M$3.9M$6.4M$11.6M$8.2M$8.9M$14.0M$3.9M$4.2M$4.3M
Book value per share$0.90$1.79$0.39$0.83$0.66$0.77$1.40$0.43$0.50$0.54
Shares outstanding2.9M2.3M16.8M14.2M12.7M11.9M10.2M9.2M8.6M8.3M
Current ratio1.622.803.516.584.697.1010.003.565.007.96
Quick ratio0.841.802.325.373.334.357.051.692.244.32
Debt / equity0.910.110.120.090.170.180.13———
Equity / assets38.9%69.0%71.2%81.1%73.2%78.1%82.3%75.9%82.8%89.5%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed August 31, 2026); data from EODHD.

BMRA financial position

At the end of fiscal 2026 (May 31, 2026), Biomerica had total assets of $6.8 million (up 13.7% from a year earlier), total liabilities of $4.1 million and shareholders' equity of $2.6 million. It held $1.3 million in cash and short-term investments against $2.4 million of debt, net debt of $1.1 million. Its current ratio was 1.62. In the latest quarter (ended August 31, 2026) total assets were $8.1 million and equity $3.6 million.

Related: BMRA income statement, BMRA cash flow statement, BMRA key metrics. See the BMRA stock overview for the latest quote and news.

BMRA balance sheet FAQ

What are Biomerica's total assets?

Biomerica reported total assets of $6.8 million at the end of fiscal 2026 (May 31, 2026), compared with $5.9 million a year earlier.

How much debt does Biomerica have?

Biomerica had $2.4 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.91.

How much cash does Biomerica have?

Biomerica held $1.3 million in cash and short-term investments at the end of fiscal 2026; with $2.4 million of debt that is net debt of $1.1 million.

What is Biomerica's book value?

Biomerica's shareholders' equity (book value) was $2.6 million at the end of fiscal 2026, or $0.90 per share.

What is Biomerica's current ratio?

Biomerica had current assets of $4.0 million and current liabilities of $2.5 million, a current ratio of 1.62 (it can cover its short-term obligations).

How much goodwill does Biomerica have?

Biomerica carried $0.2 million of goodwill and intangible assets, 3.1% of total assets, at the end of fiscal 2026.

Medical Devices: balance sheet